Lonza Group stock heads toward Jefferies investor conference

Lonza Group stock traded at 734.10 euros on Lang & Schwarz at 17:04 CET on Thursday, November 5, 2026.

Lonza announced on November 4 that it will take part in the Jefferies Global Healthcare Conference in London on November 17 and 18. CEO Wolfgang Wienand is scheduled to present and answer questions on November 18 from 15:30 to 15:55 GMT, or 16:30 to 16:55 CET, according to EQS News.

What investors will watch

The session gives investors a scheduled forum to assess Lonza's operating priorities and its medium-term growth ambitions. The company has recently kept its 2026 outlook unchanged after reporting third-quarter performance in line with expectations, while lifting its medium-term margin ambition into the high thirties.

The conference follows Lonza's agreement to acquire five Merck CDMO sites in the United States. The transaction is expected to close in mid-2027 and would expand the company's US network from four to nine sites, adding about 1,100 employees. Lonza expects the acquired operations to contribute about 250 million Swiss francs in sales in 2028, while initially operating below the group's margin level.

The presentation will be webcast live, and a replay will remain available on the Lonza investor relations page for 90 days. The appearance is therefore the next scheduled communication point before the company's full-year 2026 results.

Investors can follow the real-time quote of Lonza Group stock for further trading updates.

Current developments in the Swiss equity market can be followed through current SMI market reports.

More news and analyses are available on Lonza Group stock.